We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Using time‐weighted average change from baseline of SARS‐CoV‐2 viral load to assess impact of hydroxychloroquine as postexposure prophylaxis and early treatment for COVID‐19.
- Authors
Kumbhakar, Raaka; Neradilek, Moni; Barnabas, Ruanne V.; Stewart, Jenell; Stankiewicz Karita, Helen C.; Landovitz, Raphael J.; Kissinger, Patricia J.; Jerome, Keith R.; Paasche‐Orlow, Michael K.; Bershteyn, Anna; Chu, Helen Y.; Neuzil, Kathleen M.; Greninger, Alexander L.; Luk, Alfred; Wald, Anna; Brown, Elizabeth R.; Johnston, Christine
- Abstract
Two randomized controlled trials demonstrated no clinical benefit of hydroxychloroquine (HCQ) for either postexposure prophylaxis or early treatment of SARS‐CoV‐2 infection. Using data from these studies, we calculated the time‐weighted average change from baseline SARS‐CoV‐2 viral load and demonstrated that HCQ did not affect viral clearance.
- Subjects
COVID-19 treatment; VIRAL load; SARS-CoV-2; HYDROXYCHLOROQUINE; IMPACT loads
- Publication
Journal of Medical Virology, 2022, Vol 94, Issue 12, p6091
- ISSN
0146-6615
- Publication type
Article
- DOI
10.1002/jmv.28054